Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of segment information

	Cannabis and Medical Marijuana Segment			Facility Operations Related		Corporate and Eliminations			Consolidated
Three months ended March 31, 2023
Net revenue	$	-		$	2,175,135	$	-		$	2,175,135
Operating income (loss)		(706	)		244,054		(170,734	)		72,614
Interest income		-			-		6,660			6,660
Interest expense		-			16,163		2,796			18,959
Property additions		-			-		-			-
Depreciation and amortization		-			14,208		238			14,446
Total assets		812			3,623,663		1,607,618			5,232,093
Three months ended March 31, 2022
Net revenue	$	9,017		$	1,839,881	$	-		$	1,848,898
Operating income (loss)		5,491			187,150		(161,265	)		31,376	)
Interest income		-			-		14,353			14,353
Interest expense		-			10,386		7,821			18,207
Property additions		-			27,902		-			27,902
Depreciation and amortization		-			15,368		522			15,890
Total assets		879,789			2,411,343		1,545,786			4,836,918

Schedule of reconciliation of revenue from segments to consolidated

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

	Three Months Ended March 31,
	2023			2022
Operating loss	$	72,614		$	31,376
Gain (loss) on investments		-			(42,680	)
Interest income		6,660			14,353
Interest expense		(18,959	)		(18,207	)
Gain (loss) on ROU asset disposal		-			26,168
Other income		12,118			1,500
Income before income taxes	$	72,433		$	12,510